Leith Wheeler Investment Counsel’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$13.7M Sell
159,535
-13,788
-8% -$1.24M 1.14% 24
2025
Q4
$15.1M Sell
173,323
-6,067
-3% -$460K 1.14% 23
2025
Q3
$10.3M Sell
179,390
-10,948
-6% -$630K 0.7% 35
2025
Q2
$11.2M Buy
190,338
+18,690
+11% +$1.21M 0.8% 30
2025
Q1
$12.6M Buy
171,648
+2,178
+1% +$180K 0.87% 30
2024
Q4
$14M Sell
169,470
-6,204
-4% -$489K 1.02% 22
2024
Q3
$12.6M Sell
175,674
-7,086
-4% -$500K 0.88% 31
2024
Q2
$12.5M Buy
182,760
+97,260
+114% +$5.81M 1.08% 25
2024
Q1
$4.59M Buy
+85,500
New +$4.6M 0.45% 50

Other funds holding GMED

Leith Wheeler Investment Counsel's GMED Position: Q1 2026 in Review

Leith Wheeler Investment Counsel reduced its Globus Medical (GMED) stake by 8% in Q1 2026, selling an estimated $1.24M and leaving 159,535 shares worth $13.7M. The position accounts for 1.14% of the portfolio, ranked #24.

Leith Wheeler Investment Counsel first reported a position in GMED in Q1 2024 and has held it in 9 quarters since. The position peaked at $15.1M in Q4 2025. 603 funds tracked by Wall St. Rank hold GMED as of Q1 2026.

  • Leith Wheeler Investment Counsel held 159,535 shares of Globus Medical worth $13.7M as of Q1 2026.
  • Leith Wheeler Investment Counsel sold 13,788 Globus Medical shares in Q1 2026, an estimated $1.24M.
  • Globus Medical made up 1.14% of Leith Wheeler Investment Counsel's portfolio in Q1 2026, its #24 holding.
  • Leith Wheeler Investment Counsel first reported a position in Globus Medical in Q1 2024 and has held it in 9 quarters since.
  • Leith Wheeler Investment Counsel's Globus Medical position peaked at $15.1M in Q4 2025.
  • 603 funds tracked by Wall St. Rank held Globus Medical as of Q1 2026.

Based on Leith Wheeler Investment Counsel's 13F filing for Q1 2026, filed 7 May 2026.